Literature DB >> 17727966

Development of a novel recombinant encapsidated RNA particle: evaluation as an internal control for diagnostic RT-PCR.

Donald P King1, Nick Montague, Katja Ebert, Scott M Reid, Juliet P Dukes, Lysann Schädlich, Graham J Belsham, George P Lomonossoff.   

Abstract

This report describes the generation of novel encapsidated RNA particles and their evaluation as in-tube internal controls in diagnostic real-time reverse-transcription PCR (rRT-PCR) assays for the detection of RNA viruses. A cassette containing sequences of 2 diagnostic primer sets for foot-and-mouth disease virus (FMDV) and a set for swine vesicular disease virus (SVDV) was engineered into a full-length cDNA clone containing the RNA-2 segment of Cowpea Mosaic Virus (CPMV). After co-inoculation with a plasmid that expressed CPMV RNA-1, recombinant virus particles were rescued from cowpea plants (Vigna unguiculata). RNA contained in these particles was amplified in diagnostic rRT-PCR assays used for detection of FMDV and SVDV. Amplification of these internal controls was used to confirm that rRT-PCR inhibitors were absent from clinical samples, thereby verifying negative assay results. The recombinant CPMVs did not reduce the analytical sensitivity of the rRT-PCRs when amplification of the insert was performed in the same tube as the diagnostic target. This system provides an attractive solution to the production of internal controls for rRT-PCR assays since CPMV grows to high yields in plants, the particles are thermostable, RNase resistant and simple purification of RNA-2 containing capsids yields a preparation which is non-infectious.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17727966     DOI: 10.1016/j.jviromet.2007.07.002

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  8 in total

Review 1.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

2.  Specific Packaging of Custom RNA Molecules into Cowpea Mosaic Virus-like Particles.

Authors:  Hadrien Peyret; George P Lomonossoff
Journal:  Methods Mol Biol       Date:  2022

3.  Development of a non-infectious encapsidated positive control RNA for molecular assays to detect foot-and-mouth disease virus.

Authors:  Mikidache Madi; Valerie Mioulet; Donald P King; George P Lomonossoff; Nicholas P Montague
Journal:  J Virol Methods       Date:  2015-04-09       Impact factor: 2.014

4.  In Planta Synthesis of Designer-Length Tobacco Mosaic Virus-Based Nano-Rods That Can Be Used to Fabricate Nano-Wires.

Authors:  Keith Saunders; George P Lomonossoff
Journal:  Front Plant Sci       Date:  2017-08-18       Impact factor: 5.753

Review 5.  Applications of plant viruses in bionanotechnology.

Authors:  George P Lomonossoff; David J Evans
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

6.  Production and use of encapsidated RNA mimics as positive control reagents for SARS-CoV-2 RT-qPCR diagnostics.

Authors:  Hadrien Peyret; Elisabetta Groppelli; David Clark; Nicholas Eckersley; Tim Planche; Julian Ma; George P Lomonossoff
Journal:  J Virol Methods       Date:  2021-11-24       Impact factor: 2.014

7.  The structures of a naturally empty cowpea mosaic virus particle and its genome-containing counterpart by cryo-electron microscopy.

Authors:  Emma L Hesketh; Yulia Meshcheriakova; Rebecca F Thompson; George P Lomonossoff; Neil A Ranson
Journal:  Sci Rep       Date:  2017-04-03       Impact factor: 4.379

Review 8.  Potential Applications of Plant Biotechnology against SARS-CoV-2.

Authors:  Teresa Capell; Richard M Twyman; Victoria Armario-Najera; Julian K-C Ma; Stefan Schillberg; Paul Christou
Journal:  Trends Plant Sci       Date:  2020-04-24       Impact factor: 18.313

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.